Logo image of LINE

LINEAGE INC (LINE) Stock Fundamental Analysis

USA - NASDAQ:LINE - US53566V1061 - REIT

41.46 USD
+1.43 (+3.57%)
Last: 10/3/2025, 8:00:02 PM
41.4261 USD
-0.03 (-0.08%)
After Hours: 10/3/2025, 8:00:02 PM
Fundamental Rating

2

LINE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. LINE has a bad profitability rating. Also its financial health evaluation is rather negative. LINE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

LINE had negative earnings in the past year.
In the past year LINE had a positive cash flow from operations.
LINE Yearly Net Income VS EBIT VS OCF VS FCFLINE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.82%, LINE is doing worse than 75.19% of the companies in the same industry.
Looking at the Return On Equity, with a value of -6.36%, LINE is doing worse than 68.22% of the companies in the same industry.
With a Return On Invested Capital value of 1.10%, LINE is not doing good in the industry: 82.95% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for LINE is in line with the industry average of 3.04%.
Industry RankSector Rank
ROA -2.82%
ROE -6.36%
ROIC 1.1%
ROA(3y)-1.44%
ROA(5y)N/A
ROE(3y)-3.48%
ROE(5y)N/A
ROIC(3y)1.85%
ROIC(5y)N/A
LINE Yearly ROA, ROE, ROICLINE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

The Operating Margin of LINE (4.70%) is worse than 86.05% of its industry peers.
In the last couple of years the Operating Margin of LINE has remained more or less at the same level.
LINE has a Gross Margin of 32.30%. This is amonst the worse of the industry: LINE underperforms 88.37% of its industry peers.
LINE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.7%
PM (TTM) N/A
GM 32.3%
OM growth 3Y0.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.87%
GM growth 5YN/A
LINE Yearly Profit, Operating, Gross MarginsLINE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LINE is destroying value.
The number of shares outstanding for LINE has been increased compared to 1 year ago.
LINE has a better debt/assets ratio than last year.
LINE Yearly Shares OutstandingLINE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M 200M
LINE Yearly Total Debt VS Total AssetsLINE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

LINE has an Altman-Z score of 0.67. This is a bad value and indicates that LINE is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 0.67, LINE is doing good in the industry, outperforming 60.47% of the companies in the same industry.
LINE has a debt to FCF ratio of 42.17. This is a negative value and a sign of low solvency as LINE would need 42.17 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 42.17, LINE is doing good in the industry, outperforming 63.57% of the companies in the same industry.
A Debt/Equity ratio of 0.81 indicates that LINE is somewhat dependend on debt financing.
LINE has a better Debt to Equity ratio (0.81) than 71.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 42.17
Altman-Z 0.67
ROIC/WACC0.15
WACC7.37%
LINE Yearly LT Debt VS Equity VS FCFLINE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

LINE has a Current Ratio of 0.96. This is a bad value and indicates that LINE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.96, LINE perfoms like the industry average, outperforming 48.84% of the companies in the same industry.
LINE has a Quick Ratio of 0.96. This is a bad value and indicates that LINE is not financially healthy enough and could expect problems in meeting its short term obligations.
LINE's Quick ratio of 0.83 is in line compared to the rest of the industry. LINE outperforms 44.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.83
LINE Yearly Current Assets VS Current LiabilitesLINE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500M 1B

3

3. Growth

3.1 Past

The earnings per share for LINE have decreased strongly by -887.61% in the last year.
Looking at the last year, LINE shows a decrease in Revenue. The Revenue has decreased by -0.03% in the last year.
Measured over the past years, LINE shows a quite strong growth in Revenue. The Revenue has been growing by 12.99% on average per year.
EPS 1Y (TTM)-887.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.61%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y12.99%
Revenue growth 5YN/A
Sales Q2Q%0.9%

3.2 Future

Based on estimates for the next years, LINE will show a very strong growth in Earnings Per Share. The EPS will grow by 27.89% on average per year.
LINE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.47% yearly.
EPS Next Y96.95%
EPS Next 2Y42.15%
EPS Next 3Y27.9%
EPS Next 5YN/A
Revenue Next Year1.45%
Revenue Next 2Y2.88%
Revenue Next 3Y3.47%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LINE Yearly Revenue VS EstimatesLINE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
LINE Yearly EPS VS EstimatesLINE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -1 -2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LINE. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 702.87, which means the current valuation is very expensive for LINE.
LINE's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, LINE is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 702.87
LINE Price Earnings VS Forward Price EarningsLINE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

LINE's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as LINE.
Industry RankSector Rank
P/FCF 56.46
EV/EBITDA 14.28
LINE Per share dataLINE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
LINE's earnings are expected to grow with 27.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.15%
EPS Next 3Y27.9%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.25%, LINE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.41, LINE has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, LINE pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.25%

5.2 History

LINE has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LINE Yearly Dividends per shareLINE Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

DPN/A
EPS Next 2Y42.15%
EPS Next 3Y27.9%
LINE Yearly Income VS Free CF VS DividendLINE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 -200M -400M -600M

LINEAGE INC

NASDAQ:LINE (10/3/2025, 8:00:02 PM)

After market: 41.4261 -0.03 (-0.08%)

41.46

+1.43 (+3.57%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners33.48%
Inst Owner Change-4.1%
Ins Owners0.2%
Ins Owner Change0.09%
Market Cap9.48B
Analysts69.6
Price Target50.82 (22.58%)
Short Float %6.18%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield 5.25%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date09-30 2025-09-30 (0.5275)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-40.84%
Min EPS beat(2)-46.03%
Max EPS beat(2)-35.66%
EPS beat(4)0
Avg EPS beat(4)-162.35%
Min EPS beat(4)-466.27%
Max EPS beat(4)-35.66%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3%
Min Revenue beat(2)-5.42%
Max Revenue beat(2)-0.59%
Revenue beat(4)0
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-5.42%
Max Revenue beat(4)-0.59%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.76%
PT rev (3m)-15.55%
EPS NQ rev (1m)-83.77%
EPS NQ rev (3m)-90.05%
EPS NY rev (1m)-15.91%
EPS NY rev (3m)60.47%
Revenue NQ rev (1m)6.66%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 702.87
P/S 1.78
P/FCF 56.46
P/OCF 11.29
P/B 1.1
P/tB 2.38
EV/EBITDA 14.28
EPS(TTM)-2.93
EYN/A
EPS(NY)0.06
Fwd EY0.14%
FCF(TTM)0.73
FCFY1.77%
OCF(TTM)3.67
OCFY8.86%
SpS23.24
BVpS37.75
TBVpS17.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.82%
ROE -6.36%
ROCE 1.39%
ROIC 1.1%
ROICexc 1.1%
ROICexgc 1.49%
OM 4.7%
PM (TTM) N/A
GM 32.3%
FCFM 3.16%
ROA(3y)-1.44%
ROA(5y)N/A
ROE(3y)-3.48%
ROE(5y)N/A
ROIC(3y)1.85%
ROIC(5y)N/A
ROICexc(3y)1.86%
ROICexc(5y)N/A
ROICexgc(3y)2.54%
ROICexgc(5y)N/A
ROCE(3y)2.34%
ROCE(5y)N/A
ROICexcg growth 3Y8.4%
ROICexcg growth 5YN/A
ROICexc growth 3Y8.9%
ROICexc growth 5YN/A
OM growth 3Y0.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.87%
GM growth 5YN/A
F-Score4
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 42.17
Debt/EBITDA 6.16
Cap/Depr 76.19%
Cap/Sales 12.64%
Interest Coverage 0.7
Cash Conversion 74.2%
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.83
Altman-Z 0.67
F-Score4
WACC7.37%
ROIC/WACC0.15
Cap/Depr(3y)99.91%
Cap/Depr(5y)N/A
Cap/Sales(3y)14.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-887.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.61%
EPS Next Y96.95%
EPS Next 2Y42.15%
EPS Next 3Y27.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y12.99%
Revenue growth 5YN/A
Sales Q2Q%0.9%
Revenue Next Year1.45%
Revenue Next 2Y2.88%
Revenue Next 3Y3.47%
Revenue Next 5YN/A
EBIT growth 1Y-29.21%
EBIT growth 3Y13.12%
EBIT growth 5YN/A
EBIT Next Year378.8%
EBIT Next 3Y77.15%
EBIT Next 5YN/A
FCF growth 1Y-59.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.58%
OCF growth 3Y28.68%
OCF growth 5YN/A